Adding rituximab to CODOX-M/IVAC chemotherapy in the treatment of HIV-associated Burkitt lymphoma is safe when used with concurrent combination antiretroviral therapy.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Ferras Alwan Kirit M. Ardeshna Mark Bower |
| Publication date | May 1, 2015 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |